Veradermics, Inc. (MANE)
102.35
+3.89
(+3.95%)
USD |
NYSE |
Aug 25, 16:00
102.23
-0.12
(-0.12%)
After-Hours: 19:59
Veradermics Total Liabilities (Quarterly) : 12.12M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.12M |
| March 31, 2026 | 6.716M |
| December 31, 2025 | 9.156M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 4.718M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 108.40B |
| EyePoint, Inc. | 61.78M |
| Elanco Animal Health, Inc. | 6.973B |
| Tarsus Pharmaceuticals, Inc. | 264.41M |
| Amylyx Pharmaceuticals, Inc. | 25.40M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 826.33M |
| Shareholders Equity (Quarterly) | 814.21M |
| Debt to Equity Ratio | 0.0005 |
| Current Ratio | 70.53 |
| Net Debt Paydown Yield | -0.00% |